Blinded by the Light: The Growing Complexity of p53

Slides:



Advertisements
Similar presentations
P53 Missense Mutation Cancer. Outline Disease related to p53 Role and regulation pathway Structure of p53 Missense mutation and consequences Experiment’s.
Advertisements

Tumor-suppressor genes Tumor-suppressor genes, function like brakes, keep cell numbers down, either by inhibiting progress through.
Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects  Chi Chen, Ah-Ng Tony Kong  Trends in Pharmacological.
Chromatin Control of Developmental Dynamics and Plasticity
EMT: Matter of Life or Death?
A Time to Divide: Does the Circadian Clock Control Cell Cycle?
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
Approaching TERRA Firma: Genomic Functions of Telomeric Noncoding RNA
Is Hepatitis C Virus Carcinogenic?
Methed-Up FOXOs Can't In-Akt-ivate
Cellular Senescence in Cancer and Aging
Molecular mechanisms of diabetic renal hypertrophy
Dale Dorsett, Lena Ström  Current Biology 
p53 and Metabolism: The GAMT Connection
Transcriptional Addiction in Cancer
Filling a GAP(DH) in Caspase-Independent Cell Death
Impulse Control: Temporal Dynamics in Gene Transcription
Smads “Freeze” When They Ski
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Epigenetics Drives RAGs to Recombination Riches
Neurodevelopment on Route p63
Chromatin Proteins Do Double Duty
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm
Volume 130, Issue 4, Pages (August 2007)
Regulation of Primary Response Genes
miR-34a and the Cardiomyopathy of Senescence: SALT PNUTS, SALT PNUTS!
Mechanisms and Consequences of Alternative Polyadenylation
John D. Hayes, Albena T. Dinkova-Kostova  Molecular Cell 
Mohammad Abdul-Ghani, Lynn A. Megeney  Cell Stem Cell 
Phytochromes: Where to Start?
Tumor Suppression by p53: Fall of the Triumvirate?
Senescence in chronic liver disease: Is the future in aging?
A New FOXO Pathway Required for Leukemogenesis
Molecular Mechanisms Regulating Hair Follicle Development
Proteins Kinases: Chromatin-Associated Enzymes?
Connecting Threads: Epigenetics and Metabolism
Guarding against Collateral Damage during Chromatin Transactions
MicroRNA Functions in Stress Responses
The Role of PML in Tumor Suppression
Interactions between Retroviruses and the Host Cell Genome
Fyn-Tau-Amyloid: A Toxic Triad
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
John D. Hayes, Albena T. Dinkova-Kostova  Molecular Cell 
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
P53 and Prognosis Cell Volume 120, Issue 1, Pages 7-10 (January 2005)
Apoptosis Cell Volume 108, Issue 2, Pages (January 2002)
Keeping p53 in Check: A High-Stakes Balancing Act
Polycomb Repression under the Skin
Epigenome Maintenance in Response to DNA Damage
Modes of p53 Regulation Cell
The Expanding Cosmos of Nuclear Receptor Coactivators
Functional and Mechanistic Diversity of Distal Transcription Enhancers
Update on glucocorticoid action and resistance
aMAGEing New Players Enter the RING to Promote Ubiquitylation
Alexander Kiani, Anjana Rao, Jose Aramburu  Immunity 
Slugging It out: Fine Tuning the p53-PUMA Death Connection
Shared Principles in NF-κB Signaling
Hailing Shi, Jiangbo Wei, Chuan He  Molecular Cell 
Poised RNA Polymerase II Gives Pause for Thought
Transcriptional Regulation and Its Misregulation in Disease
Chromatin Repressive Complexes in Stem Cells, Development, and Cancer
Chromatin Modifications and Their Function
Volume 23, Issue 6, Pages (June 2013)
The 3D Genome in Transcriptional Regulation and Pluripotency
Autophagy and the Integrated Stress Response
Stem Cells Neuron Volume 46, Issue 3, Pages (May 2005)
Volume 13, Issue 3, Pages (March 2008)
Tenets of PTEN Tumor Suppression
Update on glucocorticoid action and resistance
Dendritic Tau in Alzheimer’s Disease
Presentation transcript:

Blinded by the Light: The Growing Complexity of p53 Karen H. Vousden, Carol Prives  Cell  Volume 137, Issue 3, Pages 413-431 (May 2009) DOI: 10.1016/j.cell.2009.04.037 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 p53 Responses in Mediating Tumor Suppression The control of cell survival, proliferation, and death by p53 is mediated by the regulation of expression of p53 target genes (some examples shown in blue) in the nucleus and transcriptionally independent cytoplasmic functions of p53. Most of these p53 responses have the potential to contribute to tumor suppression. Cell 2009 137, 413-431DOI: (10.1016/j.cell.2009.04.037) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 Dual Mechanisms of p53 Function in Tumor Suppression and Aging p53 can help to promote the repair and survival of damaged cells, or it can promote the permanent removal of damaged cells though death or senescence. The ultimate result of p53 activation depends on many variables, including the extent of the stress or damage. In this model, basal p53 activity or that induced by low-stress elicits the protector responses that support cell survival, control glycolysis, and promote the repair of genotoxic damage. Sustained stress or irreparable damage, on the other hand, induces the killer functions of p53 to activate cell death or senescence. Notably, the protector functions of p53 could contribute to tumor development if not properly regulated (red, dashed arrow). Some of p53’s protector functions may also help to enhance longevity, whereas the consequences of p53’s killer functions can promote aging. Cell 2009 137, 413-431DOI: (10.1016/j.cell.2009.04.037) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 p53 Contributes to Multiple Normal Processes and Disease Pathologies In addition to its well-known role as a tumor suppressor, p53 also regulates other cellular (right) and developmental processes (left). These include processes that result in positive outcomes (red arrow) and those that result in diseases or other unfavorable outcomes (black arrow). Examples of p53 target genes (blue) that are regulated by p53 to produce the indicated cellular outcomes of p53 induction are shown. Note that, in many cases, numerous targets have been identified to mediate a specific outcome, even though only one example target gene is shown here. Cell 2009 137, 413-431DOI: (10.1016/j.cell.2009.04.037) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 4 Selective Impact of p53 Modifications p53 protein domains include the transcriptional activation domain I (TAD 1, residues 20–40), the transcriptional activation domain II (TAD II, residues 40–60), the proline domain (PP, residues 60–90), the sequence-specific core DNA-binding domain (DNA-binding core, residues 100–300), the linker region (L, residues 301–324), the tetramerization domain (Tet, residues 325–356), and the lysine-rich basic C-terminal domain (++, residues 363–393). A few examples are depicted of residues that when modified by phosphorylation (P), acetylation (Ac), or ubiquitination (Ub), result in a specific cellular outcome in response to p53 activation (for example, apoptosis versus cell cycle arrest) that depends on preferential activation of the indicated target genes. Cell 2009 137, 413-431DOI: (10.1016/j.cell.2009.04.037) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 5 p53-Interacting Proteins Exert Selective Influences on p53 Target Genes and Outcomes Different proteins can bind to p53 to induce different cellular outcomes to p53 activity. Proteins that interact with the p53 DNA-binding core (green), tetramerization domain (Tet, blue), or C-terminal basic domain (++, purple) are shown. Brn3A, Hzf, c-Abl, YB1, and p18/Hamlet selectively induce p53 activation of genes encoding cell cycle regulators such as p21 to facilitate cell cycle arrest. In contrast, ASPPs, the zebrafish p53 variant delta113p53, the p53 isoform p53β, Brn3b, NFκB/p52, and Muc1 selectively activate the expression of apoptotic regulators such as PUMA, Bax, and Noxa to promote cell death. Cell 2009 137, 413-431DOI: (10.1016/j.cell.2009.04.037) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 6 Multiple Mechanisms of Differential p53 Target Gene Regulation The cellular response to p53 activation can be determined by differential target gene activation. Whether a given promoter is activated or repressed depends on the amount of p53 protein, its modification state, and the cofactors present at the promoter. p53 protein levels or modification state can also dictate which genes are targeted for transcriptional activation. The induction or repression of p53 target gene transcription can also depend on the presence of numerous coactivators or additional cooperating factors that enhance or repress p53-induced transcription. Cell 2009 137, 413-431DOI: (10.1016/j.cell.2009.04.037) Copyright © 2009 Elsevier Inc. Terms and Conditions